Synopsis
0
CEP/COS
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - EQ 100MG BASE **Federa...DOSAGE - TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21743
DOSAGE - TABLET;ORAL - EQ 150MG BASE **Federa...DOSAGE - TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21743
DOSAGE - TABLET;ORAL - EQ 25MG BASE **Federal...DOSAGE - TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21743
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Fillers, Diluents & Binders
Controlled & Modified Release
Disintegrants & Superdisintegrants
Granulation
Direct Compression
Thickeners and Stabilizers
Lubricants & Glidants
Film Formers & Plasticizers
Co-Processed Excipients
Taste Masking
Empty Capsules
Vegetarian Capsules
Coloring Agents
Rheology Modifiers
API Stability Enhancers
Chewable & Orodispersible Aids
Emulsifying Agents
Parenteral
Surfactant & Foaming Agents
Solubilizers
Topical
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
22
PharmaCompass offers a list of Erlotinib Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Erlotinib Hydrochloride manufacturer or Erlotinib Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Erlotinib Hydrochloride manufacturer or Erlotinib Hydrochloride supplier.
PharmaCompass also assists you with knowing the Erlotinib Hydrochloride API Price utilized in the formulation of products. Erlotinib Hydrochloride API Price is not always fixed or binding as the Erlotinib Hydrochloride Price is obtained through a variety of data sources. The Erlotinib Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A erlotinib HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of erlotinib HCl, including repackagers and relabelers. The FDA regulates erlotinib HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. erlotinib HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of erlotinib HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A erlotinib HCl supplier is an individual or a company that provides erlotinib HCl active pharmaceutical ingredient (API) or erlotinib HCl finished formulations upon request. The erlotinib HCl suppliers may include erlotinib HCl API manufacturers, exporters, distributors and traders.
click here to find a list of erlotinib HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A erlotinib HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of erlotinib HCl active pharmaceutical ingredient (API) in detail. Different forms of erlotinib HCl DMFs exist exist since differing nations have different regulations, such as erlotinib HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A erlotinib HCl DMF submitted to regulatory agencies in the US is known as a USDMF. erlotinib HCl USDMF includes data on erlotinib HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The erlotinib HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of erlotinib HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The erlotinib HCl Drug Master File in Japan (erlotinib HCl JDMF) empowers erlotinib HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the erlotinib HCl JDMF during the approval evaluation for pharmaceutical products. At the time of erlotinib HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of erlotinib HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a erlotinib HCl Drug Master File in Korea (erlotinib HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of erlotinib HCl. The MFDS reviews the erlotinib HCl KDMF as part of the drug registration process and uses the information provided in the erlotinib HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a erlotinib HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their erlotinib HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of erlotinib HCl suppliers with KDMF on PharmaCompass.
A erlotinib HCl written confirmation (erlotinib HCl WC) is an official document issued by a regulatory agency to a erlotinib HCl manufacturer, verifying that the manufacturing facility of a erlotinib HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting erlotinib HCl APIs or erlotinib HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a erlotinib HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of erlotinib HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing erlotinib HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for erlotinib HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture erlotinib HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain erlotinib HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a erlotinib HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of erlotinib HCl suppliers with NDC on PharmaCompass.
erlotinib HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of erlotinib HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right erlotinib HCl GMP manufacturer or erlotinib HCl GMP API supplier for your needs.
A erlotinib HCl CoA (Certificate of Analysis) is a formal document that attests to erlotinib HCl's compliance with erlotinib HCl specifications and serves as a tool for batch-level quality control.
erlotinib HCl CoA mostly includes findings from lab analyses of a specific batch. For each erlotinib HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
erlotinib HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (erlotinib HCl EP), erlotinib HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (erlotinib HCl USP).
